Search

everythinglearnresearchcommunity

for

Search:↓

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Progesterone's seizure-reducing effects are mainly due to allopregnanolone, not progesterone receptors.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Activating cannabinoid receptor 1 may help manage psoriasis by reducing certain keratins.

Axitinib treatment turned a man's grey hair back to black.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Onabotulinumtoxin-A effectively treated a painful scalp condition when other treatments failed.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

GLP-1 agonists may increase the risk of hair loss.

The skin communicates with the nervous system, and targeting neurohormones like melatonin and oxytocin could help treat skin issues.

VR1 signaling can inhibit hair growth by affecting cell processes and increasing hair growth inhibitors.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Regional nerve blocks are better than ring blocks for pain relief during PRP hair treatment.

KATP channels may help reduce itching in liver disease.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

Ruxolitinib treatment may cause eyelash growth.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.